Page last updated: 2024-09-05

varenicline and Depressive Disorder, Major

varenicline has been researched along with Depressive Disorder, Major in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's5 (50.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Anthenelli, RM; Beneventi, D; Blalock, JA; Cinciripini, PM; Green, C; Karam-Hage, M; Kypriotakis, G; Lawrence, D; Minnix, J; Morris, C1
Bastian, J; Bauer, AM; Fox, EN; Gollan, JK; Hitsman, B; Hole, A; Huffman, MD; Khan, SS; Leone, FT; Lubitz, SF; Mohr, DC; Niaura, R; Papandonatos, GD; Schnoll, RA; Veluz-Wilkins, AK; Wileyto, EP1
Colby, SM; Leggio, L; Martin, RA; Monti, PM; Rohsenow, DJ; Swift, RM; Tidey, JW1
Bruguera, E; Cedillo, S; Rejas-Gutiérrez, J1
Anthenelli, RM; Doran, N; Dubrava, S1
Anthenelli, RM; Dubrava, SJ; Morris, C; Ramey, TS; Russ, C; Tsilkos, K; Yunis, C1
Popkin, MK1
Nadeem, SS; Pirmoradi, P; Roshan, S1
Lyon, GJ1

Trials

5 trial(s) available for varenicline and Depressive Disorder, Major

ArticleYear
The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial.
    Depression and anxiety, 2022, Volume: 39, Issue:5

    Topics: Bupropion; Depression; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Polyesters; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2022
Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial.
    Addiction (Abingdon, England), 2023, Volume: 118, Issue:9

    Topics: Adult; Benzazepines; Depressive Disorder, Major; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2023
Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Addiction (Abingdon, England), 2017, Volume: 112, Issue:10

    Topics: Adult; Cigarette Smoking; Comorbidity; Counseling; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotinic Agonists; Patient Compliance; Rhode Island; Sex Factors; Smokers; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2017
Effects of Varenicline, Depressive Symptoms, and Region of Enrollment on Smoking Cessation in Depressed Smokers.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2019, 01-04, Volume: 21, Issue:2

    Topics: Adult; Aged; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Smokers; Smoking Cessation; Treatment Outcome; Varenicline

2019
Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.
    Annals of internal medicine, 2013, Sep-17, Volume: 159, Issue:6

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult

2013

Other Studies

5 other study(ies) available for varenicline and Depressive Disorder, Major

ArticleYear
Modelling a budgetary impact analysis for funding drug-based smoking cessation therapies for patients with major depressive disorder in Spain.
    European psychiatry : the journal of the Association of European Psychiatrists, 2017, Volume: 45

    Topics: Bupropion; Cost-Benefit Analysis; Depressive Disorder, Major; Female; Health Care Costs; Humans; Male; Markov Chains; Smoking; Smoking Cessation; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2017
Summaries for patients. Does varenicline help people with depression quit smoking?
    Annals of internal medicine, 2013, Sep-17, Volume: 159, Issue:6

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult

2013
Exacerbation of recurrent depression as a result of treatment with varenicline.
    The American journal of psychiatry, 2008, Volume: 165, Issue:6

    Topics: Aged; Benzazepines; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking Cessation; Varenicline

2008
Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Sep-01, Volume: 65, Issue:17

    Topics: Adult; Alcoholism; Benzazepines; Depressive Disorder, Major; Humans; Male; Mental Disorders; Nervous System Diseases; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline

2008
Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission.
    Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6

    Topics: Adult; Amphetamine-Related Disorders; Benzazepines; Borderline Personality Disorder; Depressive Disorder, Major; Drug Partial Agonism; Female; Humans; Irritable Mood; Methamphetamine; Nicotinic Agonists; Paranoid Disorders; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline

2008